PsyBio Therapeutics Initiates European Manufacturing of Proprietary Biosynthetic Psychedelic Compounds including… Jun 22, 2021
PsyBio Therapeutics Retains KCSA Strategic Communications for Investor Relations Services Apr 9, 2021